A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Status:
NOT_YET_RECRUITING
Trial end date:
2028-10-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard therapy for the treatment of metastatic NSCLC.